Pneumococcal vaccines have been instrumental in decreasing invasive disease since their introduction in the 1980s. 2021 brought regulatory changes and recent ACIP recommendations were published in the Morbidity and Mortality Weekly Report, also known as MMWR. Dr. John Schoen, Senior Clinical Manager of Evidence-Based Medicine and Drug Information shares his insights on these changes with host Gretchen Brummel.
Guest speaker: John Schoen, PharmD, BCPSSenior Clinical Manager of Evidence-Based Medicine and Drug Information Vizient Center for Pharmacy Pra...
Pneumococcal vaccines have been instrumental in decreasing invasive disease since their introduction in the 1980s. 2021 brought regulatory changes and recent ACIP recommendations were published in the Morbidity and Mortality Weekly Report, also known as MMWR. Dr. John Schoen, Senior Clinical Manager of Evidence-Based Medicine and Drug Information shares his insights on these changes with host Gretchen Brummel.
Guest speaker:
John Schoen, PharmD, BCPS
Senior Clinical Manager of Evidence-Based Medicine and Drug Information Vizient Center for Pharmacy Practice Excellence
Host:
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence
Show Notes:
Recorded in the Fall of 2023
[01:00-03:34] What’s new since March 2022 with pneumococcal vaccines
[03:35-06:51] Changes with the adult recommendations
[06:52-13:10] New recommendations from CDC as well as published recommendations for adults
[13:11-19:05] Recommendations for Pneumococcal vaccines in pediatrics
[19:06-21:46] The area of biggest risk moving forward
[21:47-24:07] What we are looking at for the future
Links | Resources:
Vizient pneumococcal vaccine side-by-side comparison Click Here
ACIP pneumococcal vaccine recommendations Click Here
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Android
RSS Feed
View more
